Symphoni

Symphoni is a proprietary Sengenics database of human autoantibody profiles

  • 10,000s of human autoantibody profiles

  • Caucasian, Chinese, Indian, African and Malay samples

  • True positive samples from cancers, autoimmune, metabolic and  neurological disorders

  • Biologically meaningful results as KREX™-based proteins have linear and  conformational epitopes

Symphoni can be used to:

  • Improve specificity of autoantibody signatures by filtering out biomarkers for other diseases and aging

Symphoni can only be accessed by:

  • Collaboration partners

  • iTAP licensees

FEATURED PRODUCTS

High-throughput autoantibody profiling against 1600+ proteins

Quantification of autoantibodies to 200+ clinically relevant CT antigens

Simultaneous screening of 100+
wild-type and mutant p53

Multi-antigen, multi-domain
COVID-19 antibody test

Sengenics - Functional Proteomics | Krex Technology | Protein Array Supplier

Sengenics is a Functional Proteomics company that leverages its patented KREX technology to discover autoantibody biomarker signatures for prediction of drug response and severe immune-related adverse events (irAEs). KREX can also be used to identify autoantibody biomarkers to diagnose cancer, autoimmune, neurodegenerative or infectious diseases with higher sensitivity and specificity than conventional diagnostic tests. Some autoantibodies that are identified as diagnostic biomarkers may be protective and have potential in themselves as therapeutic biomolecules.

Copyright 2008 – 2021 Sengenics All rights reserved | Sengenics Corporation LLC. Registered in Delaware, USA no. 5739583 | Sengenics UK Registered in England and Wales no. 12889389